NYSE:ELV
Elevance Health, Inc.
Elevance Health, Inc.'s revenue grew 12.5% in fiscal 2025 to $199.1B. Return on average equity was 13.3%, and the diluted share count fell 3.6%.Summary generated from Elevance Health, Inc.'s SEC filings. Latest annual report filed Feb 6, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$199.1B
Revenue growth+12.5%
Revenue, 5-yr CAGR+10.3%
Net margin2.8%
Return on equity13.3%
Share count change−3.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 138.6 | 156.6 | 171.3 | 177.0 | 199.1 |
| Net income | 6.2 | 5.9 | 6.0 | 6.0 | 5.7 |
Recent filings
- 4Insider transaction report
Oct 6, 2026 - 8-KRegulation FD disclosure
Sep 10, 2026 - 4Insider transaction report
Sep 4, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 15, 2026 - 8-KResults of operations and financial condition
Jul 15, 2026 - 8-KRegulation FD disclosure
Jun 10, 2026 - 8-KResults of a shareholder vote
May 13, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
Apr 22, 2026